Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers

• Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the U.S. Department of Defense.
• Nanobiotix S.A. (NASDAQ: NBTX) shares jumped 45.5% to $7.32 after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and commercialization of NBTXR3.
• T2 Biosystems, Inc. (NASDAQ: TTOO) shares rose 36% to $0.1565 after gaining over 38% on Friday.
• Jupiter Wellness, Inc. (NASDAQ: JUPW) gained 34.8% to $0.4934 after the company announced it has executed an Asset Purchase Agreement with GBB Drink Lab to acquire all operating assets including the "Safety Shot" rapid alcohol detox drink.
• NanoString Technologies, Inc. (NASDAQ: NSTG) shares gained 32.4% to $4.90 after the company said it expects second-quarter revenue to be over $44 million, above the upper end of its guidance range and the $41 million consensus estimate. The company also reiterated FY23 revenue guidance above the consensus estimate.
• Gorilla Technology Group Inc. (NASDAQ: GRRR) gained 30.8% to $6.15. Gorilla Technology shares jumped 125% on Friday after the company signed a $270 million contract with the Government of Egypt to implement a Smart Government Security Convergence solution.
• Shineco, Inc. (NASDAQ: SISI) gained 28.5% to $0.4165 after the company announced its subsidiary received marketing and distribution approval for its Cardiac 5-Minute Test from the Jiangsu Bureau of China's National Medical Products Administration.
• Alpine 4 Holdings, Inc. (NASDAQ: ALPP) shares rose 22% to $2.05 after the company said its subsidiary, Vayu Aerospace Corporation, received its first $5.25m purchase order from its $100 million supply agreement with U.S. Government contractor, All American Contracting, Inc.
• Novavax, Inc. (NASDAQ: NVAX) gained 21.2% to $8.77. The European Commission recently approved Novavax’s Nuvaxovid (NVX-CoV2373), following a positive opinion for a full authorization from the Committee for Medicinal Products for Human Use of the European Medicines Agency.
• Marker Therapeutics, Inc. (NASDAQ: MRKR) rose 19.8% to $5.20 after the company announced the European Medicines Agency granted MT-401 an Orphan Drug Designation.
• NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) gained 19% to $1.44.
• Icahn Enterprises L.P. (NASDAQ: IEP) gained 17.8% to $34.02 after Carl Icahn amended loan agreements, disconnecting his personal loans from the share price, increasing his collateral and establishing a plan to repay the loans within three years. This was an issue raised in Hindenburg Research's short report on the stock issued in May.
• Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) gained 17.5% to $8.51 after the company announced regulatory, clinical updates for TIL therapy in advanced non-small cell lung cancer.
• SOS Limited (NYSE: SOS) gained 17.4% to $5.31.
• Aravive, Inc. (NASDAQ: ARAV) climbed 17.4% to $1.55. Cantor Fitzgerald reiterated Aravive with an Overweight and maintained $18 price target.
• Advent Technologies Holdings, Inc. (NASDAQ: ADN) gained 17.4% to $0.7399.
• Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) jumped 17% to $3.03.
• Stronghold Digital Mining, Inc. (NASDAQ: SDIG) gained 16.1% to $8.16.
• Helen of Troy Limited (NASDAQ: HELE) rose 15.7% to $130.26 after the company reported better-than-expected first-quarter financial results and issued guidance.
• TMC the metals company Inc. (NASDAQ: TMC) jumped 15.3% to $2.9150 after ThinkEquity initiated coverage on the stock with a Buy rating and announced a $6 price target.
• fuboTV Inc. (NYSE: FUBO) gained 14.2% to $2.48.
• Groupon, Inc. (NASDAQ: GRPN) jumped 13.8% to $6.95.
• Siyata Mobile Inc. (NASDAQ: SYTA) shares climbed 12.9% to $0.07 after gaining around 12% on Friday.
• Lyft, Inc. (NASDAQ: LYFT) rose 11.2% to $11.26.
• Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) shares gained 7.6% to $4.7450. Black Diamond Therapeutics Director Rajeev Shah purchased 935,850 shares at an average price of $5.00 per share.

Losers

• Tivic Health Systems, Inc. (NASDAQ: TIVC) shares fell 41.4% to $0.0650 after the company priced public offering of 32.5 million shares at $0.055 per share.
• Neonode Inc. (NASDAQ: NEON) fell 33.8% to $4.85 after dropping over 8% on Friday.
• ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares dropped 19.7% to $2.81. The company announced plans to voluntarily delist from the Toronto Stock Exchange.
• Xcel Brands, Inc. (NASDAQ: XELB) dipped 19.4% to $1.16.
• Nocera, Inc. (NASDAQ: NCRA) dropped 18.4% to $1.6480.
• Presto Automation Inc. (NASDAQ: PRST) fell 18.1% to $3.49. Rajat Suri, 10% owner at Presto Automation, reported a large insider sell on July 6.
• Tattooed Chef, Inc. (NASDAQ: TTCF) fell 16.4% to $0.2175.
• Trinity Place Holdings Inc. (NYSE: TPHS) dropped 14.4% to $0.5481.
• The Aaron's Company, Inc. (NYSE: AAN) fell 12.2% to $13.41 after Loop Capital downgraded the stock from Buy to Hold.
• FOXO Technologies Inc. (NYSE: FOXO) dropped 12.2% to $0.18.
• Metalpha Technology Holding Limited (NASDAQ: MATH) declined 11.8% to $1.27.
• Shengfeng Development Limited (NASDAQ: SFWL) fell 11.3% to $8.97.
• FMC Corporation (NYSE: FMC) dropped 11.3% to $92.42 after the company issued weak revenue guidance.
• Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) fell 10.5% to $3.8899. Biodexa Ltd, subsidiary of Biodexa Pharmaceuticals, has completed the enrolment and treatment of nine pediatric patients in the ongoing Phase 1 study of MTX-110 in newly diagnosed diffuse midline gliomas.
• SunCar Technology Group Inc. (NASDAQ: SDA) dropped 9.8% to $20.05.
• MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) declined 9.7% to $1.0470.
• VOXX International Corporation (NASDAQ: VOXX) fell 8.8% to $11.53.
• 22nd Century Group, Inc. (NASDAQ: XXII) fell 8.5% to $2.45.
• Femasys Inc. (NASDAQ: FEMY) fell 7% to $0.4785.

Now Read This: This Analyst With 83% Accuracy Rate Sees Around 7% Upside In Alphabet - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts